Literature DB >> 18164593

A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.

Philip J Candilis1, Kenneth E Fletcher, Cynthia M A Geppert, Charles W Lidz, Paul S Appelbaum.   

Abstract

To characterize predictors of impairment in research decision-making capacity, we undertook a direct comparison of schizophrenia/schizoaffective (n=52), medically ill (diabetic; n=51), and non-ill (n=57) subjects. Scores on the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) were correlated with demographic variables and scores on the Positive and Negative Syndrome Scale (PANSS), Mini-Mental State Examination (MMSE), and Short-Form-36 (SF-36). Across diagnoses, cognitive capacity, physical functioning, and a diagnosis of mental illness had the greatest impact on decision-making capacity, with level of education also having an impact. 69-89% of schizophrenia/schizoaffective subjects attained MacCAT-CR subscale scores achieved by almost all comparison (98-100%) and medically ill (94-100%) subjects. Positive, negative, and general psychotic symptoms correlated with poorer scores. Prior research experience, number of queries used during interview, and emotional functioning also predicted MacCAT-CR scores. These data suggest that investigators and IRBs should consider a number of variables, many of which reach across diagnoses, as they decide which populations and individual subjects may require more intensive screening for decisional impairment or educational interventions to improve their abilities to make capable decisions about research participation.

Entities:  

Mesh:

Year:  2008        PMID: 18164593      PMCID: PMC2486336          DOI: 10.1016/j.schres.2007.11.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  28 in total

1.  Back to the future of mental capacity assessment.

Authors:  Donald R Royall
Journal:  J Am Geriatr Soc       Date:  2002-11       Impact factor: 5.562

2.  Willingness of subjects with thought disorder to participate in research.

Authors:  Philip J Candilis; Cynthia M A Geppert; Kenneth E Fletcher; Charles W Lidz; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions.

Authors:  T Grisso; P S Appelbaum; C Hill-Fotouhi
Journal:  Psychiatr Serv       Date:  1997-11       Impact factor: 3.084

5.  Decisional capacity of patients with schizophrenia to consent to research: taking stock.

Authors:  Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

6.  Capacities of hospitalized, medically ill patients to consent to treatment.

Authors:  P S Appelbaum; T Grisso
Journal:  Psychosomatics       Date:  1997 Mar-Apr       Impact factor: 2.386

Review 7.  Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: an overview.

Authors:  Dilip V Jeste; Colin A Depp; Barton W Palmer
Journal:  Schizophr Bull       Date:  2005-09-28       Impact factor: 9.306

8.  Using quality of life scores to help determine treatment: is restoring bowel continuity better than an ostomy?

Authors:  C. Y. Ko; L. C. Rusin; D. J. Schoetz; J. A. Coller; J. J. Murray; P. L. Roberts; L. Moreau
Journal:  Colorectal Dis       Date:  2002-01       Impact factor: 3.788

9.  Individual autonomy and the double-blind controlled experiment: the case of desperate volunteers.

Authors:  B P Minogue; G Palmer-Fernandez; L Udell; B N Waller
Journal:  J Med Philos       Date:  1995-02

10.  Quality of life in patients with malignant melanoma participating in a phase I trial of an autologous tumour-derived vaccine.

Authors:  L Cohen; P A Parker; J Sterner; C De Moor
Journal:  Melanoma Res       Date:  2002-10       Impact factor: 3.599

View more
  22 in total

1.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

2.  Demonstrating Patterns in the Views Of Stakeholders Regarding Ethically-Salient Issues in Clinical Research: A Novel Use of Graphical Models in Empirical Ethics Inquiry.

Authors:  Jane Paik Kim; Laura Weiss Roberts
Journal:  AJOB Empir Bioeth       Date:  2015

3.  Attitudes Regarding Enrollment in a Genetic Research Project: An Informed Consent Simulation Study Comparing Views of People With Depression, Diabetes, and Neither Condition.

Authors:  Jane Paik Kim; Katie Ryan; Laura Weiss Roberts
Journal:  J Empir Res Hum Res Ethics       Date:  2019-07-22       Impact factor: 1.742

4.  Informed consent to research in persons with schizophrenia spectrum disorders.

Authors:  Lora Humphrey Beebe; Kathlene Smith
Journal:  Nurs Ethics       Date:  2010-07       Impact factor: 2.874

5.  Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study.

Authors:  Jason Freeman; Jean Emond; Brenda W Gillespie; Paul S Appelbaum; Robert Weinrieb; Peg Hill-Callahan; Elisa J Gordon; Norah Terrault; James Trotter; April Ashworth; Mary Amanda Dew; Timothy Pruett
Journal:  Clin Transplant       Date:  2013-07-16       Impact factor: 2.863

6.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

7.  Giving voice to study volunteers: comparing views of mentally ill, physically ill, and healthy protocol participants on ethical aspects of clinical research.

Authors:  Laura Weiss Roberts; Jane Paik Kim
Journal:  J Psychiatr Res       Date:  2014-06-02       Impact factor: 4.791

8.  Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and Consent.

Authors:  Laura B Dunn; Paul E Holtzheimer; Jinger G Hoop; Helen S Mayberg; Paul S Appelbaum
Journal:  AJOB Neurosci       Date:  2011

Review 9.  [Ethical questions in clinical research with the mentally ill].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2008-09       Impact factor: 1.214

10.  Exploring the similarities and differences between medical assessments of competence and criminal responsibility.

Authors:  Gerben Meynen
Journal:  Med Health Care Philos       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.